Expiration Dates and Usage Guidelines for COVID-19 Kits

Throughout the pandemic, Aculabs has worked to meet the demand for ample COVID-19 specimen collection kits. Adequate access to such supplies remains highly important for physicians in catching COVID-19 early on in vulnerable populations. Clients who have received COVID-19 collection kits from Aculabs should continue using the kits provided, even tubes that display a

By |2022-11-10T11:21:07-05:00April 28th, 2022|Categories: News|0 Comments

Aculabs rolls out updates to Online Order web portal tools

The start of 2022 saw Aculabs roll out several new features to our online web portal, including Email Reporting for Result Notification and improved logic used in our Exception Test Flagging feature. The purpose of such functionality is to continue expanding the ways Aculabs communicates with your staff while tackling patient care. Such features

By |2022-10-28T09:34:15-04:00April 21st, 2022|Categories: News|0 Comments

QuantiFERON-TB Gold Plus now performed as in-house testing

Aculabs will be offering QuantiFERON-TB Gold Plus in-house as of April 6, 2022; the test provides highly accurate and reproducible results, single-step testing, and innovative CD8 T cell technology that provides a more comprehensive view of the immune response to TB infection. Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health

By |2022-04-21T15:41:04-04:00April 14th, 2022|Categories: News|0 Comments

Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health monitoring for patients

Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb). A person infected with MTB might end up with TB disease with clinical, radiographic, and microbiological evidence of tuberculosis, or will have no clinical evidence of TB disease and would be considered latent tuberculosis infection (LTBI); however, about 10% with LTBI will progress or

By |2022-04-21T15:41:20-04:00April 14th, 2022|Categories: Quarterly Letter|Comments Off on Letter from the Director: QuantiFERON-TB Gold Plus testing offers accuracy in health monitoring for patients
Go to Top